about
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortiumLamotrigine as prophylaxis against steroid-induced maniaConverting positive and negative symptom scores between PANSS and SAPS/SANSTuning in to the voices: a multisite FMRI study of auditory hallucinations.The Function Biomedical Informatics Research Network Data RepositoryA multi-scanner study of subcortical brain volume abnormalities in schizophrenia.Dynamic functional connectivity analysis reveals transient states of dysconnectivity in schizophrenia.Plasma catecholamine metabolites in antidepressant-exacerbated mania and psychosis.Visual hallucinations are associated with hyperconnectivity between the amygdala and visual cortex in people with a diagnosis of schizophreniaInformed consent: how much awareness is there?Functional magnetic resonance imaging of motor cortex activation in schizophrenia.Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivationMultidimensional frequency domain analysis of full-volume fMRI reveals significant effects of age, gender, and mental illness on the spatiotemporal organization of resting-state brain activity.Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.Function biomedical informatics research network recommendations for prospective multicenter functional MRI studiesHigher Dimensional Meta-State Analysis Reveals Reduced Resting fMRI Connectivity Dynamism in Schizophrenia Patients.Neuropsychological profile in adult schizophrenia measured with the CMINDSRelating Intrinsic Low-Frequency BOLD Cortical Oscillations to Cognition in Schizophrenia.Working memory and DLPFC inefficiency in schizophrenia: the FBIRN study.Neural Correlates of Schizophrenia Negative Symptoms: Distinct Subtypes Impact Dissociable Brain Circuits.ACP Journal Club. Review: lithium is associated with adverse events in patients with mood disorders.ACP Journal Club. Review: antipsychotic drugs improve symptoms, with different levels of side effects, in schizophrenia.Multimodal Fusion with Reference: Searching for Joint Neuromarkers of Working Memory Deficits in Schizophrenia.Aripiprazole once-monthly long-acting injectable for the treatment of schizophrenia.Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium.Supervised multimodal fusion and its application in searching joint neuromarkers of working memory deficits in schizophrenia.Impact of autocorrelation on functional connectivity.No Health Without Mental Health.D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder.Using new antipsychotics in your clinical practice.Modality-Dependent Impact of Hallucinations on Low-Frequency Fluctuations in Schizophrenia.Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group.Decreased hemispheric connectivity and decreased intra- and inter- hemisphere asymmetry of resting state functional network connectivity in schizophrenia.Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium.18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery.The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression.Resting-state thalamic dysconnectivity in schizophrenia and relationships with symptoms.Do schizophrenia patients want to be involved in their treatment?Disrupted network cross talk, hippocampal dysfunction and hallucinations in schizophrenia.Sponsored clinical trials and bias.
P50
Q23747506-8BD6856E-284B-426B-88A5-74992F631A78Q28375857-5345D408-13D6-4E60-8EB0-09E71D2FF7F3Q28660667-8B118DEA-170A-4740-9F9F-2113A86D143CQ30484435-B7FBF5C6-874A-4C20-96D0-2BB195B2B36FQ30679446-DC03582C-A7D7-4AE7-AE25-E8643EDD5A98Q33761026-1E12AB96-61F1-4FBF-BDB5-C74E0EDC708BQ34079239-A4A260C5-D3A2-406A-9D12-F1709AA5D659Q34133197-6346425E-C10E-4A72-A7E4-6D3A88AC344AQ34700992-63100320-AB21-43B7-BAD3-EBDC352389A7Q35347223-3C280BD7-0818-4381-9390-9CD04DA65D9BQ35553724-A6B015C0-E700-4CA5-B1FE-93EE932BD731Q35596962-5179BBE1-04BC-41D6-8A0D-972DEB145D5AQ35746529-4410FCAF-F423-426F-83C7-5EC160D1EC09Q35844926-ED2F6659-9C97-40E8-A07A-F687DC718C5FQ35951688-177A6562-C2B4-4879-AF0C-972C4B3F666BQ35959068-6040B944-9B03-47E0-87EE-9EB2A4EE4009Q36408176-53903144-83A7-4BD5-8631-16616630D0A2Q36894538-27E394EE-F22E-4D82-9777-2442D9D2F591Q37100393-96BEB420-BF93-45A5-BAA6-E062E6D9CAA6Q37200170-91FABCB8-BE16-46A5-9A5F-850AFC3E0AD6Q38026762-E0D1D71E-14EF-4125-A227-FA59A2B11D86Q38163857-C193940B-2106-4F48-A5B3-9D212C310508Q38679048-6816CAF3-C973-4CC9-B955-B6A8665B3227Q38728652-77154817-8ADF-4973-9FCE-A33AF4259F4CQ38859842-E6335C6F-95E5-4133-B035-98A8E61DBD6CQ38923439-42285AD4-4DA0-4886-A21E-19AEE6C50BC2Q41819184-6E350241-9DB3-4C7F-8DB4-E2C4D23F2E96Q42331617-413F812A-040F-45B3-A6A7-23072730BDD8Q43584036-86097693-78A2-473C-B66F-3BF0E7A71122Q46239512-60179107-A2C8-4947-AF71-A94B286B1EB5Q46340774-120CF3AF-E5D7-4625-8396-0EE1B7482C93Q46419549-7875E6C8-EDC6-4745-844A-3A673C028847Q46670697-7815DF41-6519-462E-BCEA-8ADF3C972845Q47145933-1AFE9E57-A494-40AC-A51A-8E72ACC20710Q47549851-AB633F56-EC09-4373-8FF0-08F6585DF0C2Q49144353-81853578-68AD-455D-B13C-33436E7FE379Q49996712-09CBC9CE-4392-4437-8DFA-0F663C12808BQ51918383-5A80A1E4-87E8-4172-96C3-2B6CB6EA4C36Q52639825-A6A25B3D-8CC5-4C37-A06C-0D829E2635B4Q53029347-E280F7C4-D01A-4FFE-8463-D1DDA4D5E3A0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Adrian Preda
@ast
Adrian Preda
@en
Adrian Preda
@es
Adrian Preda
@nl
type
label
Adrian Preda
@ast
Adrian Preda
@en
Adrian Preda
@es
Adrian Preda
@nl
altLabel
Adrian Preda
@en
prefLabel
Adrian Preda
@ast
Adrian Preda
@en
Adrian Preda
@es
Adrian Preda
@nl
P1053
K-8889-2013
P106
P1153
56662857400
7003821134
P2456
P2798
P31
P4012
P496
0000-0003-3373-2438